Tom Gayner acquired 2.26M Novo Nordisk shares worth $127M. That's 1.05% of their equity portfolio (32nd largest holding). The first Novo Nordisk trade was made in Q4 2009. Since then Tom Gayner bought shares five more times and sold shares on twelve occasions. The stake costed the investor $106M, netting the investor a gain of 19% so far.